Related Experiment Video
Updated: May 19, 2026

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion
Published on: July 5, 2024
[Pituitary coma].
1Bereich Endokrinologie & Diabetologie und Zentrum für In-Vitro-Diagnostik - Endokrinologie, Philipps-Universität Marburg und UKGM Universitätsklinikum Marburg, 35033, Marburg, Deutschland. kannp@med.uni-marburg.de
Severe pituitary hormone deficiencies, including corticotropic and thyrotropic axes, can cause life-threatening coma. Early hormone replacement, particularly hydrocortisone, is crucial for initial treatment and patient stabilization.
Area of Science:
- Endocrinology
- Neuroendocrinology
- Internal Medicine
Context:
- Pituitary hormone deficiencies can lead to severe clinical manifestations.
- Diagnosis can be challenging without patient history, but hypogonadism signs may offer clues.
- Laboratory findings include low pituitary and target organ hormone levels.
Purpose:
- To outline the diagnostic and initial management strategies for pituitary hormone deficiencies.
- To highlight the critical role of hormone substitution in preventing life-threatening complications.
- To emphasize the importance of intensive care monitoring and differential diagnosis.
Summary:
- Severe insufficiency of pituitary axes (corticotropic, thyrotropic) can precipitate coma.
- Low hormone levels, hyponatremia, and hypoglycemia are key diagnostic indicators.
- Immediate hydrocortisone and subsequent thyroxine substitution are vital, alongside intensive care management.
Impact:
- Provides a framework for timely diagnosis and intervention in pituitary insufficiency.
- Underscores the critical role of hormone replacement therapy in critical care settings.
- Guides differential diagnosis and long-term management planning for pituitary disorders.
Related Concept Videos
The Pituitary Gland
Traumatic Brain Injury l: Introduction
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Diabetic Ketoacidosis ll: Pathophysiology
Hepatic Encephalopathy

![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)